Co-expression of VIM and cytokeratins (CKs) is associated with a more aggressive and metastatic phenotype in breast cancer [22,25]; however our data demonstrates increased expression of VIM with an associated decrease in cytokeratin 18 levels in Clone #3. This evidence concerns the gene VIM and breast carcinoma.